Liquid formulation comprising an alpha-2 receptor agonist (e.g. clonidin) and oxybutynin (anti-muscarinic agent) for the treatment of sialorrhoea

摘要

Liquid formulation comprisinga) an alpha2 adrenoreceptor agonist eg. clonidine, brimonidine, monoxidine, lofexidine;b) oxybutynin; andc) excipients. The liquid formulation is useful for the treatment of siaiorrhoea.